A Phase 2, Multi-Center ... Study to Assess Safety and Immunogenicity of Three Doses of 3'-aminomethylnicotine-P. aeruginosa r-Exoprotein A Conjugate Vaccine (NicVAX) ...
|Effective start/end date
|4/19/06 → 9/30/08
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.